FlaggedRx← Medication recall checkHome
Class II · ModerateRecall completed

Losartan Potassium Tablets USP

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberBatch # LOA19357A, exp. date 09/2021
Where it was soldProduct was distributed to major wholesalers/distributors throughout the United States.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Failed Tablet/Capsule Specification; complaint of bulging tablet

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Distributed by / forCamber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs, Limited, Mahabubragar, India
Show the full FDA record
Full product labelLosartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs, Limited, Mahabubragar, India
Recalling firmHetero Labs Limited (Unit V)
DistributionProduct was distributed to major wholesalers/distributors throughout the United States.
Quantity43,512 bottles
Recall initiated2020-08-06
Report date2020-09-02
Recall completed2022-01-24
Recall numberD-1545-2020
ClassificationClass II
FDA statusTerminated
Origin on fileBadepalle N/A India

Related

Losartan recallsRecent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.